BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7515972)

  • 1. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    Connor RI; Ho DD
    J Virol; 1994 Jul; 68(7):4400-8. PubMed ID: 7515972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
    Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
    J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replicative characteristics of primary isolates of the human immunodeficiency virus type 1 in peripheral blood mononuclear cells, primary macrophages and CD4+ transformed T-cell lines.
    Jolly PE
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1057-65. PubMed ID: 9449539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ; Kedar P; Pope JH
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.
    Tersmette M; Gruters RA; de Wolf F; de Goede RE; Lange JM; Schellekens PT; Goudsmit J; Huisman HG; Miedema F
    J Virol; 1989 May; 63(5):2118-25. PubMed ID: 2564898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1.
    Connor RI; Paxton WA; Sheridan KE; Koup RA
    J Virol; 1996 Dec; 70(12):8758-64. PubMed ID: 8971004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
    Jurriaans S; Van Gemen B; Weverling GJ; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J
    Virology; 1994 Oct; 204(1):223-33. PubMed ID: 7916514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.
    van 't Wout AB; Blaak H; Ran LJ; Brouwer M; Kuiken C; Schuitemaker H
    J Virol; 1998 Jun; 72(6):5099-107. PubMed ID: 9573281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-syncytium-inducing HIV type 1 isolated from infected individuals replicates in MT-2 cells.
    Forte SE; Byron KS; Sullivan JL; Somasundaran M
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1613-8. PubMed ID: 7888220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1.
    Yu X; McLane MF; Ratner L; O'Brien W; Collman R; Essex M; Lee TH
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10237-41. PubMed ID: 7937869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
    de Jong JJ; Goudsmit J; Keulen W; Klaver B; Krone W; Tersmette M; de Ronde A
    J Virol; 1992 Feb; 66(2):757-65. PubMed ID: 1731110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sources.
    Lu W; Andrieu JM
    J Virol; 1992 Jan; 66(1):334-40. PubMed ID: 1727492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.
    Koot M; Keet IP; Vos AH; de Goede RE; Roos MT; Coutinho RA; Miedema F; Schellekens PT; Tersmette M
    Ann Intern Med; 1993 May; 118(9):681-8. PubMed ID: 8096374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broader tropism and higher cytopathicity for CD4+ T cells of a syncytium-inducing compared to a non-syncytium-inducing HIV-1 isolate as a mechanism for accelerated CD4+ T cell decline in vivo.
    Fouchier RA; Meyaard L; Brouwer M; Hovenkamp E; Schuitemaker H
    Virology; 1996 May; 219(1):87-95. PubMed ID: 8623557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.
    Björndal A; Deng H; Jansson M; Fiore JR; Colognesi C; Karlsson A; Albert J; Scarlatti G; Littman DR; Fenyö EM
    J Virol; 1997 Oct; 71(10):7478-87. PubMed ID: 9311827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.
    Tersmette M; de Goede RE; Al BJ; Winkel IN; Gruters RA; Cuypers HT; Huisman HG; Miedema F
    J Virol; 1988 Jun; 62(6):2026-32. PubMed ID: 3130494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.
    Tuttle DL; Anders CB; Aquino-De Jesus MJ; Poole PP; Lamers SL; Briggs DR; Pomeroy SM; Alexander L; Peden KW; Andiman WA; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):353-62. PubMed ID: 11897037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.
    Dittmar MT; Simmons G; Donaldson Y; Simmonds P; Clapham PR; Schulz TF; Weiss RA
    J Virol; 1997 Jul; 71(7):5140-7. PubMed ID: 9188581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    Cornelissen M; Mulder-Kampinga G; Veenstra J; Zorgdrager F; Kuiken C; Hartman S; Dekker J; van der Hoek L; Sol C; Coutinho R
    J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env.
    Kimata JT; Overbaugh J
    J Virol; 1997 Oct; 71(10):7629-39. PubMed ID: 9311845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.